These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8271378)
21. Total synthesis of the antiviral peptide antibiotic feglymycin. Dettner F; Hänchen A; Schols D; Toti L; Nusser A; Süssmuth RD Angew Chem Int Ed Engl; 2009; 48(10):1856-61. PubMed ID: 19180618 [TBL] [Abstract][Full Text] [Related]
22. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates]. Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741 [TBL] [Abstract][Full Text] [Related]
23. Solution-phase synthesis of an anti-human immunodeficiency virus peptide, T22 ([Tyr5,12,Lys7]-polyphemusin II), and the modification of Trp by the p-methoxybenzyl group of Cys during trimethylsilyl trifluoromethanesulfonate deprotection. Tamamura H; Otaka A; Takada W; Terakawa Y; Yoshizawa H; Masuda M; Ibuka T; Murakami T; Nakashima H; Waki M Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):12-8. PubMed ID: 7895303 [TBL] [Abstract][Full Text] [Related]
24. Peptide bond mimicry by (E)-alkene and (Z)-fluoroalkene peptide isosteres: synthesis and bioevaluation of alpha-helical anti-HIV peptide analogues. Oishi S; Kamitani H; Kodera Y; Watanabe K; Kobayashi K; Narumi T; Tomita K; Ohno H; Naito T; Kodama E; Matsuoka M; Fujii N Org Biomol Chem; 2009 Jul; 7(14):2872-7. PubMed ID: 19582296 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosides. Du J; Surzhykov S; Lin JS; Newton MG; Cheng YC; Schinazi RF; Chu CK J Med Chem; 1997 Sep; 40(19):2991-3. PubMed ID: 9301659 [No Abstract] [Full Text] [Related]
26. Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection. Tamamura H; Imai M; Ishihara T; Masuda M; Funakoshi H; Oyake H; Murakami T; Arakaki R; Nakashima H; Otaka A; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N Bioorg Med Chem; 1998 Jul; 6(7):1033-41. PubMed ID: 9730240 [TBL] [Abstract][Full Text] [Related]
27. Simple synthesis of triester analogs of oligonucleotides for use as antisense antiviral agents. Dyadchenko MA; Vinogradov SV Nucleic Acids Symp Ser; 1991; (24):272. PubMed ID: 1668689 [No Abstract] [Full Text] [Related]
28. Synthesis of antisense oligodeoxyribonucleotides and their anti-HIV activity. Gug-Kim S; Suzuki Y; Nakashima H; Yamamoto N; Takaku H Nucleic Acids Symp Ser; 1991; (25):103-4. PubMed ID: 1842040 [No Abstract] [Full Text] [Related]
29. A synthetic form of tracheal antimicrobial peptide has both bactericidal and antifungal activities. Lawyer C; Watabe M; Pai S; Bakir H; Eagleton L; Mashimo T; Watabe K Drug Des Discov; 1996 Dec; 14(3):171-8. PubMed ID: 9017361 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of the 2',3'-dideoxynucleoside derivatives of the specific binding peptide part of CD4. Uchiyama T; Yoshino H; Takemoto M; Achiwa K Nucleic Acids Symp Ser; 1991; (25):189-90. PubMed ID: 1842077 [No Abstract] [Full Text] [Related]
31. Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure. Tamamura H; Waki M; Imai M; Otaka A; Ibuka T; Waki K; Miyamoto K; Matsumoto A; Murakami T; Nakashima H; Yamamoto N; Fujii N Bioorg Med Chem; 1998 Apr; 6(4):473-9. PubMed ID: 9597190 [TBL] [Abstract][Full Text] [Related]
32. Lymphocytes and promonocytes attach to the synthetic [Tyr5,12, Lys7]- polyphemusin II peptide. Weeks BS; Nomizu M; Otaka A; Weston CA; Okusu A; Tamamura H; Matsumoto A; Yamamoto N; Fujii N Biochem Biophys Res Commun; 1994 Jul; 202(1):470-5. PubMed ID: 8037749 [TBL] [Abstract][Full Text] [Related]
33. Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR; He LY; Liu XY; Liu AP; Huang YB; Qiu C; Zhang XY; Xu JQ; Yang W; Chen YX Chem Biol Drug Des; 2011 Nov; 78(5):835-43. PubMed ID: 21801309 [TBL] [Abstract][Full Text] [Related]
34. Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation. Vértesy L; Aretz W; Knauf M; Markus A; Vogel M; Wink J J Antibiot (Tokyo); 1999 Apr; 52(4):374-82. PubMed ID: 10395273 [TBL] [Abstract][Full Text] [Related]
35. Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II). Tamamura H; Arakaki R; Funakoshi H; Imai M; Otaka A; Ibuka T; Nakashima H; Murakami T; Waki M; Matsumoto A; Yamamoto N; Fujii N Bioorg Med Chem; 1998 Feb; 6(2):231-8. PubMed ID: 9547946 [TBL] [Abstract][Full Text] [Related]
36. Basic approaches to anti-retroviral treatment. De Clercq E J Acquir Immune Defic Syndr (1988); 1991; 4(3):207-18. PubMed ID: 1704059 [No Abstract] [Full Text] [Related]
37. Inhibition of HIV replication by 19-O-n-pentyldamavaricin Fc in vitro. Ito S; Gilljams G; Wahren B; Wigzell H; Yamamoto N; Sasaki K; Onodera K J Antibiot (Tokyo); 1990 Aug; 43(8):1045-6. PubMed ID: 1976616 [No Abstract] [Full Text] [Related]
38. Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides. Arar K; Aubertin AM; Roche AC; Monsigny M; Mayer R Bioconjug Chem; 1995; 6(5):573-7. PubMed ID: 8974456 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TIBO) derivatives. Kukla MJ; Breslin HJ; Pauwels R; Fedde CL; Miranda M; Scott MK; Sherrill RG; Raeymaekers A; Van Gelder J; Andries K J Med Chem; 1991 Feb; 34(2):746-51. PubMed ID: 1995896 [TBL] [Abstract][Full Text] [Related]